Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508649 | 1.00 | HTR2A (0.38) | HTR2AMLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL14508325 | 0.93 | PDK2 (0.41) | PDK2 | |
| SCHEMBL13382415 | 0.93 | PDK2 (0.41) | PDK2 | |
| SCHEMBL13382425 | 0.91 | PDK2 (0.43) | PDK2 | |
| SCHEMBL31065872 | 0.89 | TDP2 (0.38) | TDP2 | |
| SCHEMBL29649835 | 0.89 | TDP2 (0.38) | TDP2 | |
| SCHEMBL1419163 | 0.89 | TDP2 (0.38) | TDP2 | |
| SCHEMBL24401666 | 0.89 | ELANE (0.39) | PGRTDP2 | |
| SCHEMBL13445385 | 0.88 | PDK2 (0.39) | HTR2AMLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL9957725 | 0.86 | PDK2 (0.34) | HTR2AMLNRNR1I2CHRM2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112500326-A | Hole transport/exciton blocking material with high triplet state energy level and high glass transition temperature, preparation and application | 华南理工大学 | 2021-03-16 | — | — | CN | claimed |
| CN-106188112-A | A kind of 2 substituted asymmetric fluorine boron complexation two pyrroles's methine derivants of thienyl and preparation method thereof | 东莞理工学院 | 2016-12-07 | — | — | CN | claimed |
| CN-103725203-B | Adhensive membrane, for its adhesive composition and the display unit comprising it | 第毛织株式会社 | 2016-08-17 | — | — | CN | claimed |
| CN-105732680-A | Median alkoxy phenyl substituted and 2, 6 site strong electron donating group substituted BODIPY (4,4'-difluoro-4-bora-3a,4a-diaza-sindacene) derivative and preparation method thereof | 东莞理工学院 | 2016-07-06 | — | — | CN | claimed |
| WO-2008146975-A1 | NOVEL ORGANIC DYE CONTAINING N-ARYLCARBAZOLE MOIETY AND PREPARATION THEREOF | DONGJIN SEMICHEM CO., LTD (KR) | 2008-12-04 | — | — | WO | claimed |
| JP-11035532-A | — | — | None | — | — | JP | disclosed |
| JP-7206734-A | — | — | None | — | — | JP | disclosed |
| US-12479976-B2 | Cured product, optical element, optical apparatus, and imaging apparatus | CANON KABUSHIKI KAISHA (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-4381026-B1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | IDEMITSU KOSAN CO (JP) | 2025-09-24 | — | — | EP | disclosed |
| US-20240389459-A1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-11-21 | — | — | US | disclosed |
| US-20240244972-A1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | IDEMITSU KOSAN CO., LTC. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240244972-A1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | IDEMITSU KOSAN CO., LTC. (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-0879868-B1 | Organic compound and electroluminescent device using the same | CANON KK (JP) | 2002-04-03 | — | — | EP | disclosed |
| JP-2001039934-A | AMINE COMPOUND | MITSUI CHEMICALS INC | 2001-02-13 | — | — | JP | disclosed |
| JP-H1135532-A | ORGANIC COMPOUND AND LIGHT EMISSION DEVICE USING THE SAME | CANON INC | 1999-02-09 | — | — | JP | disclosed |
| EP-0879868-A2 | Organic compound and electroluminescent device using the same | CANON KABUSHIKI KAISHA (JP) | 1998-11-25 | — | — | EP | disclosed |
| EP-0482884-B1 | Electrophotographic photosensitive member | CANON KK (JP) | 1996-01-03 | — | — | EP | disclosed |
| JP-H07206734-A | PRODUCTION OF 2-IODOLUORENE COMPOUND | TEIKOKU CHEM IND CORP LTD | 1995-08-08 | — | — | JP | disclosed |
| US-5227271-A | Phthalocyanine charge generating layer, fluorene charge transporting layer | CANON KABUSHIKI KAISHA (JP) | 1993-07-13 | — | — | US | disclosed |
| EP-0482884-A1 | Electrophotographic photosensitive member | CANON KABUSHIKI KAISHA (JP) | 1992-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240389459-A1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | DDT, ODC1, AOC2 | HTR2A 4499/4885MLNR 3395/4885NR1I2 1327/4885 |
| US-20240244972-A1 | COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND | DDT, ODC1, AOC2 | HTR2A 4499/4885MLNR 3395/4885NR1I2 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.